Insmed Incorporated Provides Sales Guidance for the Full Year 2023 and 2024
The company anticipates 2024 global ARIKAYCE revenues to be between $340 million and $360 million, representing 15% year-over-year growth at the midpoint compared to 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.8 USD | -0.48% | +1.97% | -19.97% |
1st Jan change | Capi. | |
---|---|---|
-19.97% | 3.68B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |